Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 431

1.

Pulmonary Pathology Society Perspective on the 2018 American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society (ATS/ERS/JRS/ALAT) Idiopathic Pulmonary Fibrosis Clinical Practice Guidelines.

Hariri LP, Smith ML, Mino-Kenudson M, Allen TC, Attanoos R, Borczuk A, Burke L, Cagle PT, Capelozzi V, Dacic S, Guinee D, Raparia K, Roden AC, Roy-Chowdhuri S, Sholl LM, Beasley MB, Churg A.

Ann Am Thorac Soc. 2020 Jan 16. doi: 10.1513/AnnalsATS.201910-801PS. [Epub ahead of print] No abstract available.

PMID:
31945306
2.

A 64-Year-Old Man With Rapidly Progressive Respiratory Failure and Pneumomediastinum.

Kwon M, Mira-Avendano I, Khoor A, Mallea J.

Chest. 2020 Jan;157(1):e5-e8. doi: 10.1016/j.chest.2019.07.026.

PMID:
31916971
3.

Transforming growth factor beta induces fibroblasts to express and release the immunomodulatory protein PD-L1 into extracellular vesicles.

Kang JH, Jung MY, Choudhury M, Leof EB.

FASEB J. 2019 Dec 12. doi: 10.1096/fj.201902354R. [Epub ahead of print]

PMID:
31907984
4.

Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.

Patel RB, Li E, Benefield BC, Swat SA, Polsinelli VB, Carr JC, Shah SJ, Markl M, Collins JD, Freed BH.

ESC Heart Fail. 2020 Jan 5. doi: 10.1002/ehf2.12565. [Epub ahead of print]

5.

Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-β.

Yin X, Choudhury M, Kang JH, Schaefbauer KJ, Jung MY, Andrianifahanana M, Hernandez DM, Leof EB.

Sci Signal. 2019 Dec 17;12(612). pii: eaax4067. doi: 10.1126/scisignal.aax4067.

PMID:
31848318
6.

Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide.

Mitev A, Christ L, Feldmann D, Binder M, Möller K, Kanne AM, Hügle T, Villiger PM, Voll RE, Finzel S, Kollert F.

Arthritis Res Ther. 2019 Dec 2;21(1):262. doi: 10.1186/s13075-019-2057-x.

7.

Improved pulmonary 129 Xe ventilation imaging via 3D-spiral UTE MRI.

Willmering MM, Niedbalski PJ, Wang H, Walkup LL, Robison RK, Pipe JG, Cleveland ZI, Woods JC.

Magn Reson Med. 2019 Dec 1. doi: 10.1002/mrm.28114. [Epub ahead of print]

PMID:
31788858
8.

Family history of rheumatologic, autoimmune, and non-autoimmune diseases and risk of rheumatoid arthritis.

Kronzer VL, Crowson CS, Sparks JA, Myasoedova E, Davis J 3rd.

Arthritis Care Res (Hoboken). 2019 Nov 30. doi: 10.1002/acr.24115. [Epub ahead of print]

PMID:
31785183
9.

Quantitative CT Analysis of Diffuse Lung Disease.

Chen A, Karwoski RA, Gierada DS, Bartholmai BJ, Koo CW.

Radiographics. 2020 Jan-Feb;40(1):28-43. doi: 10.1148/rg.2020190099. Epub 2019 Nov 29.

PMID:
31782933
10.

Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis.

Kronzer VL, Crowson CS, Sparks JA, Myasoedova E, Davis JM 3rd.

Mayo Clin Proc. 2019 Dec;94(12):2488-2498. doi: 10.1016/j.mayocp.2019.08.010. Epub 2019 Nov 20.

PMID:
31759675
11.

An ex vivo technique for quantifying mouse lung injury using ultrasound surface wave elastography.

Zhou B, Schaefbauer KJ, Egan AM, Carmona Porquera EM, Limper AH, Zhang X.

J Biomech. 2020 Jan 2;98:109468. doi: 10.1016/j.jbiomech.2019.109468. Epub 2019 Oct 31.

PMID:
31708243
12.

Urokinase Plasminogen Activator Overexpression Reverses Established Lung Fibrosis.

Horowitz JC, Tschumperlin DJ, Kim KK, Osterholzer JJ, Subbotina N, Ajayi IO, Teitz-Tennenbaum S, Virk A, Dotson M, Liu F, Sicard D, Jia S, Sisson TH.

Thromb Haemost. 2019 Dec;119(12):1968-1980. doi: 10.1055/s-0039-1697953. Epub 2019 Nov 8.

PMID:
31705517
13.

Reflux-Aspiration in Chronic Lung Disease.

Lee AS, Lee JS, He Z, Ryu JH.

Ann Am Thorac Soc. 2019 Nov 7. doi: 10.1513/AnnalsATS.201906-427CME. [Epub ahead of print]

PMID:
31697575
14.

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.

Haak AJ, Kostallari E, Sicard D, Ligresti G, Choi KM, Caporarello N, Jones DL, Tan Q, Meridew J, Diaz Espinosa AM, Aravamudhan A, Maiers JL, Britt RD Jr, Roden AC, Pabelick CM, Prakash YS, Nouraie SM, Li X, Zhang Y, Kass DJ, Lagares D, Tager AM, Varelas X, Shah VH, Tschumperlin DJ.

Sci Transl Med. 2019 Oct 30;11(516). pii: eaau6296. doi: 10.1126/scitranslmed.aau6296.

PMID:
31666402
15.
16.

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.

Hickson LJ, Langhi Prata LGP, Bobart SA, Evans TK, Giorgadze N, Hashmi SK, Herrmann SM, Jensen MD, Jia Q, Jordan KL, Kellogg TA, Khosla S, Koerber DM, Lagnado AB, Lawson DK, LeBrasseur NK, Lerman LO, McDonald KM, McKenzie TJ, Passos JF, Pignolo RJ, Pirtskhalava T, Saadiq IM, Schaefer KK, Textor SC, Victorelli SG, Volkman TL, Xue A, Wentworth MA, Wissler Gerdes EO, Zhu Y, Tchkonia T, Kirkland JL.

EBioMedicine. 2019 Sep;47:446-456. doi: 10.1016/j.ebiom.2019.08.069. Epub 2019 Sep 18.

17.

Methicillin-Resistant Staphylococcus aureus Infection and Treatment Options.

Chalmers SJ, Wylam ME.

Methods Mol Biol. 2020;2069:229-251. doi: 10.1007/978-1-4939-9849-4_16.

PMID:
31523777
18.

Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma.

Hinze AM, Lin CT, Hussien AF, Perin J, Venado A, Golden JA, Boin F, Brown RH, Wise RA, Wigley FM.

Rheumatology (Oxford). 2019 Aug 27. pii: kez341. doi: 10.1093/rheumatology/kez341. [Epub ahead of print]

PMID:
31504916
19.

Mechanisms of lung disease development in rheumatoid arthritis.

Wang D, Zhang J, Lau J, Wang S, Taneja V, Matteson EL, Vassallo R.

Nat Rev Rheumatol. 2019 Oct;15(10):581-596. doi: 10.1038/s41584-019-0275-x. Epub 2019 Aug 27. Review.

PMID:
31455869
20.

Comparing effectiveness of prognostic tests in idiopathic pulmonary fibrosis.

Moua T, Lee AS, Ryu JH.

Expert Rev Respir Med. 2019 Oct;13(10):993-1004. doi: 10.1080/17476348.2019.1656069. Epub 2019 Aug 26.

PMID:
31405303

Supplemental Content

Loading ...
Support Center